The Ministry of Justice registered amendments to the rules for classifying prescription and over-the-counter medicines on 12 November 2026, under registration number 3430-2.
A medicine’s status will be determined during state registration, amendments to registration documents or renewal of its registration certificate.
Assessment for over-the-counter status will consider, among other factors:
whether the medicine can be used safely without continuous supervision by a healthcare professional;
whether it causes physical or psychological dependence;
the risks of misuse, overdose and prolonged use;
whether instructions are clear, complete and understandable to consumers;
findings from pharmacovigilance and monitoring after the medicine enters the market.
Information on over-the-counter classification by foreign regulatory authorities recognised by the World Health Organization will also be considered.
Medicines containing two or more active ingredients may also qualify for over-the-counter status. Each active ingredient must be available without a prescription individually.
Their combined use must be supported by clinical and scientific evidence. A positive benefit–risk balance and low risks of interactions and misuse are also required.
Following a refusal to grant over-the-counter status, an applicant may reapply once the reasons for refusal have been addressed or new safety and efficacy data become available.
The competent authority may also review a medicine’s classification in response to new evidence, monitoring findings or changes in legislation.
Official source: Lex.uz — order registered under No. 3430-2.